Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 1

NCT04409691

SCMC Trial on KHE With KMP (V.2020)

a phase I trial focusing on safety and efficacy of prednison shock plus sirolimus maintenance in treating Kaposiform hemangioendothelioma (KHE) with Kasabach-Me…

China20 participantsStarted 2020-07-01

Treatment: prednison and Sirolimus, prednison